Grant Novartis Ag Transaction History
Grant
- $201 Million
- Q3 2024
A detailed history of Grant transactions in Novartis Ag stock. As of the latest transaction made, Grant holds 3,189 shares of NVS stock, worth $341,478. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,189
Previous 3,210
0.65%
Holding current value
$341,478
Previous $341,000
7.33%
% of portfolio
0.18%
Previous 0.18%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,432Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.3 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$867 Million0.23% of portfolio
-
Morgan Stanley New York, NY7.42MShares$794 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.95MShares$637 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...